tiprankstipranks
Aligos Therapeutics Announces Chief Medical Officer Resignation
PremiumCompany AnnouncementsAligos Therapeutics Announces Chief Medical Officer Resignation
2M ago
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
PremiumPress Releases
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
2M ago
Aligos Therapeutics to present data on ALG-097558 at ESCMID
PremiumThe Fly
Aligos Therapeutics to present data on ALG-097558 at ESCMID
2M ago
Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
PremiumPress ReleasesAligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
3M ago
Aligos Therapeutics initiates Phase 2a HERALD study of ALG-055009
PremiumThe Fly
Aligos Therapeutics initiates Phase 2a HERALD study of ALG-055009
4M ago
Aligos Therapeutics on the Brink: The Urgent Race to Maintain Nasdaq Listing and Avoid Delisting Consequences
PremiumCompany Announcements
Aligos Therapeutics on the Brink: The Urgent Race to Maintain Nasdaq Listing and Avoid Delisting Consequences
4M ago
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
PremiumPress ReleasesAligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
4M ago
Aligos Therapeutics, Inc. (ALGS) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Aligos Therapeutics, Inc. (ALGS) Q4 Earnings Cheat Sheet
4M ago
Aligos Therapeutics Launches Stock Option Exchange Program
PremiumCompany Announcements
Aligos Therapeutics Launches Stock Option Exchange Program
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100